tyrosine and Endometrial Neoplasms

tyrosine has been researched along with Endometrial Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, A; Hsueh, S; Lai, CH; Lin, CY; Lin, YJ; Tsai, CL; Wang, HS; Wang, TH; Wu, HM1
Fuchs, D; Grahmann, AV; Klieber, M; Ledochowski, M; Neurauter, G; Sperner-Unterweger, B; Zeimet, A1
Hua, SF; Wang, YM; Xue, FX; Zhang, LZ; Zhao, J1
Berry, E; Clardy, J; Hardt, JL; Kim, JJ; Lurain, JR1
Ahn, MY; Jung, JH; Kim, HS; Na, YJ1
Arbell, A; Danilenko, M; Karas, M; Kleinman, D; LeRoith, D; Levy, J; Roberts, CT; Sharoni, Y1
Danilenko, M; Fishman, D; Karas, M; LeRoith, D; Levy, J; Sharoni, Y1

Other Studies

7 other study(ies) available for tyrosine and Endometrial Neoplasms

ArticleYear
Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; ErbB Receptors; Estradiol; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Tamoxifen; Tyrosine

2013
Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8.
    Cancer letters, 2008, Dec-08, Volume: 272, Issue:1

    Topics: Biomarkers; Biomarkers, Tumor; Cystadenocarcinoma; Endometrial Neoplasms; Female; HIV Infections; Humans; Isoprostanes; Lymphocyte Activation; Neoplasm Staging; Neopterin; Ovarian Neoplasms; Oxidative Stress; Phenylalanine; Receptors, Tumor Necrosis Factor, Type II; Sepsis; Tyrosine; Uterine Neoplasms

2008
[Expression and activation of insulin receptor substrate-1 in endometrial carcinoma].
    Zhonghua fu chan ke za zhi, 2008, Volume: 43, Issue:6

    Topics: Adenocarcinoma; C-Peptide; Case-Control Studies; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Insulin Receptor Substrate Proteins; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tyrosine

2008
Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.
    Gynecologic oncology, 2009, Volume: 112, Issue:2

    Topics: Apoptosis; Cell Division; Cell Growth Processes; Cell Line, Tumor; Cell Nucleus; Endometrial Neoplasms; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; G2 Phase; Humans; RNA, Small Interfering; Transfection; Tyrosine

2009
A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Gynecologic oncology, 2008, Volume: 108, Issue:1

    Topics: Acetylation; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Disulfides; Dose-Response Relationship, Drug; Endometrial Neoplasms; Enzyme Inhibitors; Female; Histone Deacetylase Inhibitors; Histones; Humans; Tyrosine

2008
Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins.
    Endocrinology, 1996, Volume: 137, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Cell Division; Endometrial Neoplasms; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Phosphorylation; Piperidines; Raloxifene Hydrochloride; Receptor, IGF Type 1; Tamoxifen; Tumor Cells, Cultured; Tyrosine

1996
Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in ishikawa endometrial cancer cells.
    The Journal of biological chemistry, 1997, Jun-27, Volume: 272, Issue:26

    Topics: 3T3 Cells; Animals; Endometrial Neoplasms; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Membrane Proteins; Mice; Phosphorylation; Receptor, IGF Type 1; Tyrosine

1997